Manchester_Score_SCC_lung v.1
The Manchester score for prognosis in small cell lung cancer helps to provide a 2 yr prediction of small cell carcinoma of the lung
The Manchester score for prognosis in small cell lung cancer helps to provide a 2 yr prediction of small cell carcinoma of the lung. The scoring system may help in tracking new treatment protocols and for the sake of comparing treatment efficacies.
The score ranges from 0 to 6 with a combination of laboratory test results, one physical finding (that of extensive stage disease) and a Karnofsky performance status score (< 60 scoring 1 point). Manchester score Two year survival (%) ≤1 16.2 2 - 3 2.5 ≥4 0
Do not use alone for prognostic purposes without also in combination with other supporting evidence and sound clinical judgement
Ref. 1: Cerny, T; Blair V, Anderson H et al. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. International Journal of Cancer. 1987, (2): 146–149. Validation
openEHR-EHR-OBSERVATION.manchester_score_for_prognosis_in_small_cell_lung_cancer, openEHR-EHR-OBSERVATION.lab_test-urea_and_electrolytes, openEHR-EHR-OBSERVATION.karnofsky_performance_status_scale, openEHR-EHR-EVALUATION.manchester_score_assessment
